Loading clinical trials...

COMPLETEDPhase 1NCT02251457

Study of Ranolazine in Myotonia Congenita, Paramyotonia Congenita and Myotonic Dystrophy Type 1

The purpose of this study is to gather preliminary data to determine if ranolazine is a safe and effective treatment for the symptoms of myotonia congenital, paramyotonia congenita, and myotonic dystr...

Lead sponsor: Ohio State University•1 U.S. locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Clareo turns complex medical information into clear understanding you can use.

Bring this clarity to your next appointment.

Keep all your medical notes and next steps in one place.

Start Free Trial

Related studies

RECRUITINGPhase 1/2

Study of ATX-01 in Participants With DM1

NCT06300307 · Myotonic Dystrophy 1

RECRUITINGNA

Gait Analysis Parameter and Upper Limb Evaluation in Adult Patients With Neurological or Metabolic Pathology

NCT07136844 · Neuromuscular Diseases, Obesity (Disorder), and more

RECRUITING

Myotonic Dystrophy Family Registry

NCT02398786 · Myotonic Dystrophy, Congenital Myotonic Dystrophy, and more

Enrolling By InvitationPhase 3

Global Open-Label Extension Study of Del-desiran for the Treatment of DM1

NCT07008469 · Myotonic Dystrophy Type 1, DM1, and more

Enrolling By Invitation

A Multicenter Phenotype-Genotype Analysis of DM1 Patients in China

NCT06101940 · Myotonic Dystrophy 1

View all related studies →

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: March 5, 2019Terms

Trial snapshot

StatusCOMPLETED

PhasePHASE1

Enrollment35

Start dateAug 2014

Last updatedMar 5, 2019

Condition

Myotonia Congenita Paramyotonia Congenita Myotonic Dystrophy 1

Locations shown

The Ohio State University Wexner Medical Center

Columbus, Ohio

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: March 5, 2019Data synced to Clareo: May 10, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions